We studied 19 patients (pts) as compassionate case, with an age between 17 and 44 years (mean 29 ys), with a duration of epilepsy between 5 and 30 years, all with diagnosis of drug-resistant epilepsy. The pts were 13 with partial epilepsy, 3 with Lennox-Gastaut syndrome, 2 with multifocal partial epilepsy with non progressive brain damage and 1 with Lafora disease. All pts have been followed for a period between 12 and 40 months. In 2 (10.5%) pts we observed a complete disappearance of the seizures, and in 3 (15.8%) a greater than 50% reduction in total seizure number. Tolerance to Vigabatrin was good and no patient was withdrawn because of side effects.

VALUTAZIONE DELLA RISPOSTA A LUNGO TERMINE AL VIGABATRIN NELLE EPILESSIE FARMACO-RESISTENTI: STUDIO DI 19 CASI / R. Mai, M.P. Canevini, C. Di Marco, L. Minotti, A. Saltarelli, A. Iudice, U. Aguglia, P. Nichelli, R. Canger. - In: BOLLETTINO-LEGA ITALIANA CONTRO L'EPILESSIA. - ISSN 0394-560X. - 74(1991), pp. 203-204.

VALUTAZIONE DELLA RISPOSTA A LUNGO TERMINE AL VIGABATRIN NELLE EPILESSIE FARMACO-RESISTENTI: STUDIO DI 19 CASI

M.P. Canevini
Secondo
;
R. Canger
Ultimo
1991

Abstract

We studied 19 patients (pts) as compassionate case, with an age between 17 and 44 years (mean 29 ys), with a duration of epilepsy between 5 and 30 years, all with diagnosis of drug-resistant epilepsy. The pts were 13 with partial epilepsy, 3 with Lennox-Gastaut syndrome, 2 with multifocal partial epilepsy with non progressive brain damage and 1 with Lafora disease. All pts have been followed for a period between 12 and 40 months. In 2 (10.5%) pts we observed a complete disappearance of the seizures, and in 3 (15.8%) a greater than 50% reduction in total seizure number. Tolerance to Vigabatrin was good and no patient was withdrawn because of side effects.
Settore MED/26 - Neurologia
1991
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/201901
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact